Skip to main content
. 2024 Apr 18;73(6):106. doi: 10.1007/s00262-024-03682-w

Fig. 2.

Fig. 2

Overall survival in patients treated with pembrolizumab stratified by pembrolizumab setting (cohort A: patients progressed during first-line platinum base chemotherapy; cohort B: patients recurred within < 1y since the completion of adjuvant/neoadjuvant therapy), sex, smoking attitude and ECOG-PS